FIELD: medicine; oncology.
SUBSTANCE: group of inventions relates to the field of medicine, namely to oncology; it is intended for the treatment of lymphoma in a human patient. Methods for the treatment of lymphoma, in particular T-cell lymphoma, include administration to the patient of effective amount of cerdulatinib or its pharmaceutically acceptable salt or solvate. The use of a composition containing effective amount of cerdulatinib or its pharmaceutically acceptable salt or solvate for the treatment of T-cell lymphoma is also presented.
EFFECT: use of the group of inventions provides efficient and safe treatment of lymphoma in a human patient.
32 cl, 12 dwg, 8 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATING CANCER USING APILIMOD | 2016 |
|
RU2738934C2 |
| MEDICINES, APPLICATIONS AND METHODS | 2015 |
|
RU2712283C2 |
| USE OF CHIDAMIDE IN COMBINATION WITH R-CHOP AND DRUG COMBINATION | 2019 |
|
RU2802620C2 |
| TREATING MALIGNANT TUMOURS USING MODULATORS OF PI3-KINASE ISOFORMS | 2013 |
|
RU2702908C2 |
| TREATING MALIGNANT TUMORS USING PIZ-KINASE ISOFORM MODULATORS | 2014 |
|
RU2705204C2 |
| DOSING STRATEGY REDUCING CYTOKINE RELEASE SYNDROME FOR CD3/C20 BISPECIFIC ANTIBODIES | 2019 |
|
RU2799529C2 |
| USE OF MITOXANTHRON LIPOSOME FOR THE TREATMENT OF NON-HODGKIN'S LYMPHOMA | 2019 |
|
RU2804477C2 |
| DEVICES AND METHODS FOR TREATMENT USING ADOPTIVE CELL THERAPY | 2018 |
|
RU2795984C2 |
| METHOD FOR ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY STRENGTHENING | 2011 |
|
RU2627660C2 |
| COMPOSITIONS AND METHODS FOR TREATING DISEASE | 2007 |
|
RU2482877C2 |
